<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126040">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01861574</url>
  </required_header>
  <id_info>
    <org_study_id>HR 15330</org_study_id>
    <nct_id>NCT01861574</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception</brief_title>
  <official_title>TMS Effects on Pain Perception</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to investigate the effects of Transcranial Magnetic
      Stimulation on pain perception.  TMS is a non - invasive technique that uses electromagnetic
      pulses to temporarily stimulate specificc brain area in awake people ( without the need for
      surgery, anesthetic, or other invasive procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Morphine equivalents</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 72 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Gastric Bypass Surgery Pain Management</condition>
  <arm_group>
    <arm_group_label>Surgery Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gastric-Bypass Surgery Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real TMS:  Active Comparator</intervention_name>
    <description>2 ( 20 minute) sessions of TMS</description>
    <arm_group_label>Surgery Patients</arm_group_label>
    <other_name>2 (20 min) sessions of Transcranial Magnetic Stimulation (TMS).  One following surgery and one within 24 hours.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham TMS: Sham Comparator</intervention_name>
    <description>102 seconds of sham or active tms.</description>
    <arm_group_label>Gastric-Bypass Surgery Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>1-2 seconds of TMS either of Sham or Active.</description>
    <arm_group_label>Gastric-Bypass Surgery Patients</arm_group_label>
    <other_name>You will receive either Sham or Active TMS for 1-2 seconds.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult gastric by-pass patients 18 to 60 years old

        Exclusion Criteria:

          -  Non gastric by -pass patients.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Borckardt</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Psychiatry Brain Stimulation lab</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425-5712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <lastchanged_date>May 21, 2013</lastchanged_date>
  <firstreceived_date>April 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
